BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 18798728)

  • 1. Elective fresh frozen plasma in the critically ill: what is the evidence?
    Verghese SG
    Crit Care Resusc; 2008 Sep; 10(3):264-8. PubMed ID: 18798728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for indications of fresh frozen plasma.
    Stanworth SJ; Hyde CJ; Murphy MF
    Transfus Clin Biol; 2007 Dec; 14(6):551-6. PubMed ID: 18430602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The evidence-based use of FFP and cryoprecipitate for abnormalities of coagulation tests and clinical coagulopathy.
    Stanworth SJ
    Hematology Am Soc Hematol Educ Program; 2007; ():179-86. PubMed ID: 18024627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology.
    Levi M; Toh CH; Thachil J; Watson HG
    Br J Haematol; 2009 Apr; 145(1):24-33. PubMed ID: 19222477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fresh frozen plasma and platelet transfusion for nonbleeding patients in the intensive care unit: benefit or harm?
    Gajic O; Dzik WH; Toy P
    Crit Care Med; 2006 May; 34(5 Suppl):S170-3. PubMed ID: 16617262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fresh frozen plasma transfusion in critically ill patients.
    Lauzier F; Cook D; Griffith L; Upton J; Crowther M
    Crit Care Med; 2007 Jul; 35(7):1655-9. PubMed ID: 17522577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of fresh-frozen plasma transfusion on prothrombin time and bleeding in patients with mild coagulation abnormalities.
    Abdel-Wahab OI; Healy B; Dzik WH
    Transfusion; 2006 Aug; 46(8):1279-85. PubMed ID: 16934060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A survey of physicians' reasons to transfuse plasma and platelets in the critically ill: a prospective single-centre cohort study.
    Vlaar AP; in der Maur AL; Binnekade JM; Schultz MJ; Juffermans NP
    Transfus Med; 2009 Aug; 19(4):207-12. PubMed ID: 19706138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fresh frozen plasma use in a tertiary referral hospital.
    Nicholls MD; Au-Yeung D; Iannella M
    J Qual Clin Pract; 1994 Jun; 14(2):77-84. PubMed ID: 8049856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The status of blood coagulation preparations within the scope of modern hemotherapy in surgical patients].
    Kretschmer V
    Beitr Infusionsther; 1989; 24():134-50. PubMed ID: 2481530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Warfarin reversal emerging as the major indication for fresh frozen plasma use at a tertiary care hospital.
    Ozgonenel B; O'Malley B; Krishen P; Eisenbrey AB
    Am J Hematol; 2007 Dec; 82(12):1091-4. PubMed ID: 17674360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Warfarin-induced bleeding complications - clinical presentation and therapeutic options.
    Wiedermann CJ; Stockner I
    Thromb Res; 2008; 122 Suppl 2():S13-8. PubMed ID: 18549907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a multi-center randomised clinical trial on prophylactic transfusion of fresh frozen plasma: implications for future trials.
    Müller MC; de Haan RJ; Vroom MB; Juffermans NP
    Transfus Med; 2014 Oct; 24(5):292-6. PubMed ID: 25202858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical issues in hematology: anemia, thrombocytopenia, coagulopathy, and blood product transfusions in critically ill patients.
    Drews RE
    Clin Chest Med; 2003 Dec; 24(4):607-22. PubMed ID: 14710693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guideline for the use of fresh-frozen plasma. Medical Directors Advisory Committee, National Blood Transfusion Council.
    S Afr Med J; 1998 Oct; 88(10):1344-7. PubMed ID: 9807194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fresh frozen plasma prepared with amotosalen HCl (S-59) photochemical pathogen inactivation: transfusion of patients with congenital coagulation factor deficiencies.
    de Alarcon P; Benjamin R; Dugdale M; Kessler C; Shopnick R; Smith P; Abshire T; Hambleton J; Matthew P; Ortiz I; Cohen A; Konkle BA; Streiff M; Lee M; Wages D; Corash L
    Transfusion; 2005 Aug; 45(8):1362-72. PubMed ID: 16078927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response of hemophilia A with bleeding to fresh dry plasma.
    Krutvacho T; Chuansumrit A; Isarangkura P; Pintadit P; Hathirat P; Chiewsilp P
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():169-73. PubMed ID: 7886565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transfusion of fresh-frozen plasma in critically ill patients with a coagulopathy before invasive procedures: a randomized clinical trial (CME).
    Müller MC; Arbous MS; Spoelstra-de Man AM; Vink R; Karakus A; Straat M; Binnekade JM; de Jonge E; Vroom MB; Juffermans NP
    Transfusion; 2015 Jan; 55(1):26-35; quiz 25. PubMed ID: 24912653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of fresh frozen plasma usage at the University Hospital Center Rijeka.
    Balen S; Caser L; Ivanković E; Samardzija M; Ivanković Z; Vcev A
    Coll Antropol; 2009 Dec; 33(4):1375-81. PubMed ID: 20102096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrospective evaluation of a method to predict fresh-frozen plasma dosage in anticoagulated patients.
    Frazee LA; Bourguet CC; Gutierrez W; Elder-Arrington J; Elackattu AE; Haller NA
    Am J Ther; 2008; 15(2):111-8. PubMed ID: 18356630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.